Acetazolamide and N-acetylcysteine in the treatment of chronic mountain sickness (Monge's disease).
Document Type
Journal Article
Publication Date
12-1-2017
Journal
Respiratory physiology & neurobiology
Volume
246
Inclusive Pages
1-8
DOI
10.1016/j.resp.2017.07.005
Keywords
Acetazolamide; Acetylcysteine; Adult; Altitude Sickness; Analysis of Variance; Blood Gas Analysis; Carbonic Anhydrase Inhibitors; Chi-Square Distribution; Chronic Disease; Cobalt; Double-Blind Method; Drug Therapy, Combination; Female; Free Radical Scavengers; Hematocrit; Humans; Male; Middle Aged; Peru; Prospective Studies; Severity of Illness Index; Treatment Outcome
APA Citation
Sharma, S., Gralla, J., Ordonez, J., Hurtado, M., Swenson, E., Schoene, R., Kelly, J., Callacondo, D., Rivard, C., Roncal-Jimenez, C., Sirota, J., Fuquay, R., Jackson, B., Swenson, K., Johnson, R., Hurtado, A., & Escudero, E. (2017). Acetazolamide and N-acetylcysteine in the treatment of chronic mountain sickness (Monge's disease).. Respiratory physiology & neurobiology, 246 (). http://dx.doi.org/10.1016/j.resp.2017.07.005
Peer Reviewed
1
